Nectar Lifesciences Limited — Board Meeting, 23-01-2026: Outcome of Board Meeting
23-01-2026 | 05:15 pm
23-01-2026 | 05:15 pm
Nectar Lifesciences' board approved a major strategic pivot, expanding into construction, real estate, and infrastructure development. This significant diversification requires shareholder nod for a new MOA. M/s. VDR & Associates were appointed as internal auditors for two financial years.
No comments yet. Be the first to comment!
